Alejandra Bruna

Director at Cycle Pharmaceuticals


Dr Alejandra Bruna is a cancer biologist who leads the Preclinical Modelling of Paediatric Cancer Evolution team at the Institute of Cancer Research, London. Dr Bruna leads and contributes to preclinical programmes using improved patient-derived tumour models building towards an integrative and personalised approach to cancer medicine.

Dr Bruna obtained her Ph.D. from the University of Barcelona, followed by two postdoctoral fellowships at Mount Sinai School of Medicine, New York City and Vall d’Hebron Institute, Barcelona.

Dr Bruna coordinated and co-led one of the largest translational research efforts in the academia setting by developing and validating a framework for deep molecular and phenotypically annotated patient-derived tumour xenografts (PDXs) and short-term cultures of PDX cells with Professor Carlos Caldas at the Cancer Research UK Cambridge Institute. Dr Bruna is now expanding her experience and expertise into paediatric cancers by leading a team at the ICR to help achieve kinder and smarter treatments for children with cancer.


  • Director

    Current role

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.